UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 31

Sortiert nach

Evaluating the impact of varied compliance to lung cancer screening recommendations using a microsimulation model

Cancer causes & control, 2017-09, Vol.28 (9), p.947-958

2017

Link zum Volltext

Verfügbarkeit prüfen

Impact of U.S. Preventive Services Task Force lung cancer screening update on drivers of disparities in screening eligibility

Cancer medicine (Malden, MA), 2023-02, Vol.12 (4), p.4647-4654

2023

Link zum Volltext

Verfügbarkeit prüfen

Personal history of cancer as a risk factor for second primary lung cancer: Implications for lung cancer screening

Cancer medicine (Malden, MA), 2024-03, Vol.13 (5), p.e7069-n/a

2024

Link zum Volltext

Verfügbarkeit prüfen

Worst-Case Conditional Value-at-Risk Minimization for Hazardous Materials Transportation

Transportation science, 2016-11, Vol.50 (4), p.1174-1187

2016

Link zum Volltext

Verfügbarkeit prüfen

Risk-Based lung cancer screening: A systematic review

Lung cancer (Amsterdam, Netherlands), 2020-09, Vol.147, p.154-186

2020

Link zum Volltext

Verfügbarkeit prüfen

Routing hazardous materials on time-dependent networks using conditional value-at-risk

Transportation research. Part C, Emerging technologies, 2013-12, Vol.37, p.73-92

2013

Link zum Volltext

Verfügbarkeit prüfen

Comparative Effectiveness of Up To Three Lines of Chemotherapy Treatment Plans for Metastatic Colorectal Cancer

MDM policy & practice, 2017-07, Vol.2 (2), p.2381468317729650-2381468317729650

2017

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force

JAMA : the journal of the American Medical Association, 2021-03, Vol.325 (10), p.988

2021

Link zum Volltext

Verfügbarkeit prüfen

A risk‐based framework for assessing real‐time lung cancer screening eligibility that incorporates life expectancy and past screening findings

Cancer, 2021-12, Vol.127 (23), p.4432-4446

2021

Link zum Volltext

Verfügbarkeit prüfen

Lung cancer screening status and acceptability of a personalized approach in Texas

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e22516-e22516

2023

Link zum Volltext

Verfügbarkeit prüfen

Estimating sojourn time and sensitivity of screening for ovarian cancer using a Bayesian framework

JNCI : Journal of the National Cancer Institute, 2024-07

2024

Link zum Volltext

Verfügbarkeit prüfen

Disparities of National Lung Cancer Screening Guidelines in the US Population

JNCI : Journal of the National Cancer Institute, 2020-11, Vol.112 (11), p.1136-1142

2020

Link zum Volltext

Verfügbarkeit prüfen

A Comparative Modeling Analysis of Risk-Based Lung Cancer Screening Strategies

JNCI : Journal of the National Cancer Institute, 2020-05, Vol.112 (5), p.466-479

2020

Link zum Volltext

Verfügbarkeit prüfen

Cancer risk assessment in patients with persistent pulmonary nodules and its correlation with cancer-free survival

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.8569-8569

2023

Link zum Volltext

Verfügbarkeit prüfen

Risk Model-Based Lung Cancer Screening : A Cost-Effectiveness Analysis

Annals of internal medicine, 2023-03, Vol.176 (3), p.320

2023

Link zum Volltext

Verfügbarkeit prüfen

Acceptability of Personalized Lung Cancer Screening Program Among Primary Care Providers

Cancer prevention research (Philadelphia, Pa.), 2024-02, Vol.17 (2), p.51

2024

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Alternative Diagnostic Follow-up Intervals for Lung Reporting and Data System Criteria on the Effectiveness of Lung Cancer Screening

Journal of the American College of Radiology, 2021-12, Vol.18 (12), p.1614-1623

2021

Link zum Volltext

Verfügbarkeit prüfen

The Impact of Model Assumptions on Personalized Lung Cancer Screening Recommendations

Medical decision making, 2024-07, Vol.44 (5), p.497-511

2024

Link zum Volltext

Verfügbarkeit prüfen

Development and Validation of a Multivariable Lung Cancer Risk Prediction Model That Includes Low-Dose Computed Tomography Screening Results: A Secondary Analysis of Data From the National Lung Screening Trial

JAMA network open, 2019-03, Vol.2 (3), p.e190204-e190204

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5769: Disparities in uptake of levonorgestrel-releasing intrauterine system (LNG-IUS): implications for uterine cancer primary prevention

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.5769-5769

2023

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer Screening

JAMA oncology, 2021-12, Vol.7 (12), p.1833

2021

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of laparoscopic disease assessment in patients with newly diagnosed advanced ovarian cancer

Gynecologic oncology, 2021-04, Vol.161 (1), p.56-62

2021

Link zum Volltext

Verfügbarkeit prüfen

A Cost-Effectiveness Analysis of Lung Cancer Screening With Low-Dose Computed Tomography and a Diagnostic Biomarker

JNCI cancer spectrum, 2021-12, Vol.5 (6)

2021

Link zum Volltext

Verfügbarkeit prüfen

Benchmarking lung cancer screening programmes with adaptive screening frequency against the optimal screening schedules derived from the ENGAGE framework: a comparative microsimulation studyResearch in context

EClinicalMedicine, 2024-08, Vol.74, p.102743

2024

Link zum Volltext

Verfügbarkeit prüfen

Benchmarking lung cancer screening programmes with adaptive screening frequency against the optimal screening schedules derived from the ENGAGE framework: a comparative microsimulation study

EClinicalMedicine, 2024-08, Vol.74, p.102743, Article 102743

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(25)

Publikationsform

Sprache

Englisch
(31)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Evaluating the impact of varied compliance to lung cancer screening recommendations using a microsimulation model

Impact of U.S. Preventive Services Task Force lung cancer screening update on drivers of disparities in screening eligibility

Personal history of cancer as a risk factor for second primary lung cancer: Implications for lung cancer screening

Worst-Case Conditional Value-at-Risk Minimization for Hazardous Materials Transportation

Risk-Based lung cancer screening: A systematic review

Routing hazardous materials on time-dependent networks using conditional value-at-risk

Comparative Effectiveness of Up To Three Lines of Chemotherapy Treatment Plans for Metastatic Colorectal Cancer

Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force

A risk‐based framework for assessing real‐time lung cancer screening eligibility that incorporates life expectancy and past screening findings

Lung cancer screening status and acceptability of a personalized approach in Texas

Estimating sojourn time and sensitivity of screening for ovarian cancer using a Bayesian framework

Disparities of National Lung Cancer Screening Guidelines in the US Population

A Comparative Modeling Analysis of Risk-Based Lung Cancer Screening Strategies

Cancer risk assessment in patients with persistent pulmonary nodules and its correlation with cancer-free survival

Risk Model-Based Lung Cancer Screening : A Cost-Effectiveness Analysis

Acceptability of Personalized Lung Cancer Screening Program Among Primary Care Providers

Evaluation of Alternative Diagnostic Follow-up Intervals for Lung Reporting and Data System Criteria on the Effectiveness of Lung Cancer Screening

The Impact of Model Assumptions on Personalized Lung Cancer Screening Recommendations

Development and Validation of a Multivariable Lung Cancer Risk Prediction Model That Includes Low-Dose Computed Tomography Screening Results: A Secondary Analysis of Data From the National Lung Screening Trial

Abstract 5769: Disparities in uptake of levonorgestrel-releasing intrauterine system (LNG-IUS): implications for uterine cancer primary prevention

Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer Screening

Cost-effectiveness of laparoscopic disease assessment in patients with newly diagnosed advanced ovarian cancer

A Cost-Effectiveness Analysis of Lung Cancer Screening With Low-Dose Computed Tomography and a Diagnostic Biomarker

Benchmarking lung cancer screening programmes with adaptive screening frequency against the optimal screening schedules derived from the ENGAGE framework: a comparative microsimulation studyResearch in context

Benchmarking lung cancer screening programmes with adaptive screening frequency against the optimal screening schedules derived from the ENGAGE framework: a comparative microsimulation study

Suchergebnisse filtern